| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/25/2004 | US6740777 Mercaptoalkyl benzoic acid derivative are useful for inhibiting naaladase (acetylated alpha-linked acidic dipeptidase/n-/) enzyme activity |
| 05/25/2004 | US6740750 Ribozyme sequences related to hiv resistance |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740670 Thiazolidine derivatives and its use as antifungal agent |
| 05/25/2004 | US6740667 Antimicrobial agent |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740652 Topical administration of an ophthalmologically effective amount of an oxazolidinone derivative |
| 05/25/2004 | US6740642 Macrolides with antibacterial activity |
| 05/25/2004 | US6740635 Aids therapy, respiratory syncytial virus |
| 05/25/2004 | US6740515 Recombinant adenovirus |
| 05/25/2004 | US6740490 Screening for sensitivity to mystery swine disease virus infection by transfecting cells with cd antigens; animal husbandry |
| 05/25/2004 | US6740485 Identification of genes responsible for the virulence of staphylococcus bacteria, which allows for identification of new anti-bacterial agents and mutants that can be used as vaccines |
| 05/25/2004 | US6740326 Water-free topical application composition for treatment of nail diseases and nail care consisting of antimycotic agent and lower alkyl ester of lactic acid, malic acid, tartaric acid or citric acid as penetration promoting carrier |
| 05/25/2004 | US6740325 Peptide-based vaccine for influenza |
| 05/25/2004 | US6740309 Delivery of compounds for the treatment of migraine through an inhalation route |
| 05/25/2004 | US6740308 Composition comprising condensation aerosol formed by volatilizing antihistamine under conditions effective to produce heated vapor and condensing to form condensation aerosol particles having less than 5% degradation products |
| 05/25/2004 | US6740307 Delivery of β-blockers through an inhalation route |
| 05/25/2004 | CA2267059C Sordarin derivatives |
| 05/25/2004 | CA2091712C Use of a chemically-stabilised chlorite matrix for the parenteral treatment of hiv infections |
| 05/21/2004 | WO2004042002A2 Compounds for modulating rna interference |
| 05/21/2004 | WO2004041867A2 Camelidae antibodies against imminoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | WO2004041865A2 Stabilized single domain antibodies |
| 05/21/2004 | WO2004041864A2 Passive hyperimmune antibody therapy in the treatment of anthrax |
| 05/21/2004 | WO2004041863A2 Single domain antibodies directed against interferon- gamma and uses therefor |
| 05/21/2004 | WO2004041862A2 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | WO2004041855A1 Peptides for preventing, diagnosing and treating animal and/or human leptospirosis |
| 05/21/2004 | WO2004041849A1 Epstein barr virus peptide epitopes, polyepitopes and delivery system therefor |
| 05/21/2004 | WO2004041837A1 Novel cytarabine monophosphate prodrugs |
| 05/21/2004 | WO2004041834A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
| 05/21/2004 | WO2004041818A1 Anti-infective agents |
| 05/21/2004 | WO2004041794A1 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
| 05/21/2004 | WO2004041790A1 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 05/21/2004 | WO2004041758A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonistics |
| 05/21/2004 | WO2004041299A1 Dc-sign blockers and their use for preventing or treating viral infections. |
| 05/21/2004 | WO2004041260A1 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
| 05/21/2004 | WO2004041209A2 Transcription factor modulating compounds and methods of use thereof |
| 05/21/2004 | WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/21/2004 | WO2004041158A2 Rifalazil compositions and therapeutic regimens |
| 05/21/2004 | WO2004026326A3 Antigen uptake receptor for candida albicans on dendritic cells |
| 05/21/2004 | WO2004024925A8 Collectin-complement activating protein chimeras |
| 05/21/2004 | WO2004018473A3 Azapurine derivatives |
| 05/21/2004 | WO2004005476A3 Nucleic acid compositions for stimulating immune responses |
| 05/21/2004 | WO2003094834A3 Mucosal vaccines with chitosan adjuvant and meningococcal antigens |
| 05/21/2004 | WO2003089462A3 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003072725A3 Recombinant negative strand virus rna expression systems and vaccines |
| 05/21/2004 | WO2003053399A3 Methods for wet granulating azithromycin |
| 05/21/2004 | WO2003049766A8 Method of purifying hepatitis a virus particles and vaccine preparation |
| 05/21/2004 | WO2002102307B1 Nucleoside vaccine adjuvants |
| 05/21/2004 | WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 05/21/2004 | WO2002067952A8 Prophylactic teat treatment |
| 05/21/2004 | WO2002061105A8 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2543376A1 Interferon antagonists useful for the treatment of interferon related diseases |
| 05/21/2004 | CA2505326A1 Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders |
| 05/21/2004 | CA2505325A1 Stabilized single domain antibodies |
| 05/21/2004 | CA2505316A1 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 05/21/2004 | CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| 05/20/2004 | US20040097736 Can induce biosynthesis of various cytokines and are useful in treatment of a variety of conditions including viral diseases and neoplastic diseases |
| 05/20/2004 | US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity |
| 05/20/2004 | US20040097706 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097702 Thiopeptide compounds |
| 05/20/2004 | US20040097594 Sulfonamide inhibitors of aspartyl protease |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097560 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097559 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| 05/20/2004 | US20040097551 As inhibitors of glucosylceramide synthase; for therapy and prophylaxis |
| 05/20/2004 | US20040097543 Use of cyclic 2,4-diphosphoclycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations |
| 05/20/2004 | US20040097542 To induce the biosynthesis of various cytokines; therapy of viral diseases and neoplastic diseases |
| 05/20/2004 | US20040097539 Hsp inductor |
| 05/20/2004 | US20040097537 6-phenylbenzonaphthyridines |
| 05/20/2004 | US20040097515 Having reduced cardiac toxicity; for therapy of infections |
| 05/20/2004 | US20040097502 For therapy and prophylaxis of disorders characterised by overexpression of transforming growth factor |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097495 Method for treating fibrotic diseases or other indications IIIC |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097490 Novel heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as B-lactamase inhibitors and antibacterials |
| 05/20/2004 | US20040097471 For therapy and prophylaxis of influenza infection |
| 05/20/2004 | US20040097462 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/20/2004 | US20040097461 Methods and compositions for treating hepatitis C Virus |
| 05/20/2004 | US20040097456 Using a cytokine for prophylaxis, therapy and diagnosis of skin related growth disorders in mammals |
| 05/20/2004 | US20040097434 For therapy of inflammatory diseases and conditions in humans and animals |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040097420 Proteasome regulation of NF-kB activity |
| 05/20/2004 | US20040097403 Linkable sialyl lewis x analogs |
| 05/20/2004 | US20040097402 Therapy for infections; bactericides; synergistic mixtures |
| 05/20/2004 | US20040096973 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096843 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 05/20/2004 | US20040096815 Comprises compared proteomic and/or compared transcriptomic and/or compared genomic analysis; enzyme-linked immunosorbent assay (ELISA) |
| 05/20/2004 | US20040096566 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096465 Novel receptors for $1(helicobater pyroli) and use thereof |
| 05/20/2004 | US20040096464 Inactivated influenza virus vaccine for nasal or oral application |
| 05/20/2004 | US20040096463 Influenza antigen preparation obtainable by the following process, in the manufacture of an intradermal flu vaccine: (i) harvesting of virus-containing material from a culture; (ii) clarification of the harvested material to remove |
| 05/20/2004 | US20040096451 Preventing, treating or ameliorating symptoms associated with respiratory syncytial virus (RSV), parainfluenza virus (PIV), and/or human metapneumovirus (hMPV) infection, the methods comprising administering to a subject an effective amount of |
| 05/20/2004 | US20040096450 Determining the prophylactic suitability and quality control of compositions, such as intravenous immunoglobulin mixtures and Fac proteins for use in such methods, of preparing compositions for treating such disorders. |